Medico Intercontinental Ltd Financials
Company Logo

Medico Intercontinental Ltd Financial Statement

Medico Intercontinental Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue29.04
Operating Expense27.26
Net Profit0.99
Net Profit Margin3.41
Earning Per Share0.99
EBIDTA1.71
Effective Tax Rate22.03
Invest in Medico Intercontinental Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Medico Intercontinental Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual44.04
Operating Expenses Annual41.43
Operating Profit Annual3.03
Interest Annual0.22
Depreciation0.18
Net Profit Annual1.90
Tax Annual0.73

Medico Intercontinental Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning4.95
Cash Flow from Operations5.73
Cash Flow from Investing-6.65
Cash Flow from Financing-1.63
Cash Flow at the End2.41

Medico Intercontinental Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)6.86
PBIT Margin (%)6.45
PBT Margin (%)-22.96
Net PROFIT Margin (%)4.31
Return On Networth / Equity (%)5.40
Return On Networth /Employed (%)7.73
Return On Assets (%)5.13
Total Debt / Equity (X)0.05
Asset Turnover Ratio (%)1.19

Medico Intercontinental Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.33
Total Current Assets Annual22.02
Non Current Assets Annual17.43
Total Shareholders Funds Annual36.10
Total Assets Annual39.44

Medico Intercontinental Ltd Earning Calls

EPS (INR)

Expected

1.63

Reported

1.63

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 22, 2024, Medico Intercontinental Ltd has a market capitalization of 39.84 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Medico Intercontinental Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Medico Intercontinental Ltd recorded a total revenue of approximately 44.04 Cr marking a significant milestone in the company's financial performance.
Medico Intercontinental Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..
Medico Intercontinental Ltd's current PE ratio is 20.97.
Medico Intercontinental Ltd's ROCE averaged 10.7% from the FY ending March 2022 to 2024, with a median of 7.7%. It peaked at 16.9% in March 2022, reflecting strong capital efficiency over the period..
Medico Intercontinental Ltd's latest EBIT is Rs. 2.84 Cr, surpassing the average EBIT of Rs. 2.65 Cr over the 5 years..